HOTCHKIS & WILEY's GSK Position Overview
HOTCHKIS & WILEY (via Hotchkis & Wiley Capital Management LLC) currently holds 3.66 M shares of GSK plc (GSK) worth $179.38 M, representing 0.54% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 14 quarters.
Based on 13F filings, HOTCHKIS & WILEY has maintained a strategic position in GSK, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 1.1 M shares. Largest reduction occurred in Q4 2025, reducing 944,270 shares.
Analysis based on 13F filings available since 2013 Q2
HOTCHKIS & WILEY's GSK plc (GSK) Holding Value Over Time
Track share changes against reported price movement
Quarterly GSK plc (GSK) Trades by HOTCHKIS & WILEY
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -944,270 | Reduce 20.52% | 3.66 M | $49.04 |
| Q3 2025 | +45,580 | Add 1.00% | 4.6 M | $43.16 |
| Q2 2025 | -81,428 | Reduce 1.76% | 4.56 M | $38.40 |
| Q1 2025 | -3,240 | Reduce 0.07% | 4.64 M | $38.74 |
| Q4 2024 | +1.1 M | Add 31.03% | 4.64 M | $33.82 |
| Q3 2024 | +833,080 | Add 30.75% | 3.54 M | $40.88 |
| Q2 2024 | -30,217 | Reduce 1.10% | 2.71 M | $38.50 |
| Q1 2024 | -10,066 | Reduce 0.37% | 2.74 M | $42.87 |
| Q4 2023 | -82,570 | Reduce 2.92% | 2.75 M | $37.06 |
| Q3 2023 | -33,650 | Reduce 1.17% | 2.83 M | $36.25 |
| Q2 2023 | -28,200 | Reduce 0.97% | 2.87 M | $35.64 |
| Q1 2023 | -32,220 | Reduce 1.10% | 2.89 M | $35.58 |
| Q4 2022 | -69,272 | Reduce 2.31% | 2.93 M | $35.14 |
| Q3 2022 | +3 M | New Buy | 3 M | $29.43 |
HOTCHKIS & WILEY's GSK plc Investment FAQs
HOTCHKIS & WILEY first purchased GSK plc (GSK) in Q3 2022, acquiring 2,995,258 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
HOTCHKIS & WILEY has held GSK plc (GSK) for 14 quarters since Q3 2022.
HOTCHKIS & WILEY's largest addition to GSK plc (GSK) was in Q3 2022, adding 2,995,258 shares worth $88.15 M.
According to the latest 13F filing for Q4 2025, HOTCHKIS & WILEY's firm, Hotchkis & Wiley Capital Management LLC, owns 3,657,931 shares of GSK plc (GSK), valued at approximately $179.38 M.
As of the Q4 2025 filing, GSK plc (GSK) represents approximately 0.54% of HOTCHKIS & WILEY's publicly disclosed stock portfolio, making it one of their key holdings.
HOTCHKIS & WILEY's peak holding in GSK plc (GSK) was 4,641,289 shares, as reported at the end of Q4 2024.